JN
John Newman Canaccord Genuity Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
5.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
90%
Neutral
10%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Technology
Software - Infrastructure
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Downgraded
| $6 |
32%
upside
| 2 | +57% |
0
%
| 13 Jan ‘26 6 days ago |
|
|
|
Buy
Maintained
| $18 |
117%
upside
| 1 | +1.6% |
0
%
| 6 Jan ‘26 13 days ago |
|
|
|
Buy
Maintained
| $130 |
89%
upside
| 2 | -12% |
0
%
| 8 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $1,057 |
44%
upside
| 2 | +5.8% |
0
%
| 4 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $10 |
75%
upside
| 1 | +9.2% |
0
%
| 3 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $126 |
21%
upside
| 1 | +8.4% |
0
%
| 12 Nov ‘25 2 months ago |
|
|
|
Buy
Maintained
| $21 |
103%
upside
| 1 | -9.2% |
0
%
| 21 Oct ‘25 3 months ago |
|